Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1.
Contassot
Emmanuel
E
Laboratory of Tumor Immunology, University Hospital, Geneva, Switzerland.
Wilmotte
Rick
R
Tenan
Mirna
M
Belkouch
Marie-Claude
MC
Schnüriger
Valérie
V
de Tribolet
Nicolas
N
Burkhardt
Karim
K
Dietrich
Pierre-Yves
PY
Bourkhardt
Karim
K
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D001095:Arachidonic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D063385:Cannabinoid Receptor Modulators / Q000494:pharmacology* / Q000627:therapeutic use; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D063388:Endocannabinoids; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects / Q000235:genetics; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D053284:Polyunsaturated Alkamides; D012333:RNA, Messenger / Q000378:metabolism; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors / Q000378:metabolism; D043885:Receptor, Cannabinoid, CB2 / Q000037:antagonists & inhibitors / Q000378:metabolism; D011955:Receptors, Drug / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism
D000970:Antineoplastic Agents; D001095:Arachidonic Acids; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D053284:Polyunsaturated Alkamides; D012333:RNA, Messenger; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D011955:Receptors, Drug; C078814:anandamide